2 news items
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI
3 Jun 24
as of May 31, 2024 (the "Grant Date") pursuant to the Company's 2022 Inducement Stock Incentive Plan
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KPTI
1 Apr 24
as of March 31, 2024 (the "Grant Date") pursuant to the Company's 2022 Inducement Stock Incentive Plan
- Prev
- 1
- Next